Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic

J Am Acad Dermatol. 2020 Dec;83(6):1753-1755. doi: 10.1016/j.jaad.2020.08.049. Epub 2020 Aug 18.

Authors

Robert Stavert¹, Ahou Meydani-Korb², Dianne de Leon², Rebecca Osgood³, Jessamyn Blau⁴, Thien Luu²

Affiliations

¹ Division of Dermatology, Cambridge Health Alliance, Cambridge, Massachusetts. Electronic address: Rstavert@challiance.org.
² Division of Dermatology, Cambridge Health Alliance, Cambridge, Massachusetts.
³ Department of Pathology, Cambridge Health Alliance, Cambridge, Massachusetts.
⁴ Department of Internal Medicine, Cambridge Health Alliance, Cambridge, Massachusetts.

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Viral / blood*
Betacoronavirus / immunology
Betacoronavirus / isolation & purification*
COVID-19
COVID-19 Testing
Chilblains / blood
Chilblains / diagnosis
Chilblains / etiology*
Child
Clinical Laboratory Techniques / statistics & numerical data*
Coronavirus Infections / blood
Coronavirus Infections / complications
Coronavirus Infections / diagnosis*
Coronavirus Infections / immunology
Female
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral / blood
Pneumonia, Viral / complications
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / immunology
SARS-CoV-2
Young Adult

Substances

Antibodies, Viral